14 research outputs found

    Detailed Clinical and Psychological Phenotype of the X-linked HNRNPH2-Related Neurodevelopmental Disorder

    Get PDF
    Objective: To expand the clinical phenotype of the X-linked HNRNPH2-related neurodevelopmental disorder in 33 individuals. Methods: Participants were diagnosed with pathogenic or likely pathogenic variants in HNRNPH2 using American College of Medical Genetics and Genomics/Association of Molecular Pathology criteria, largely identified via clinical exome sequencing. Genetic reports were reviewed. Clinical data were collected by retrospective chart review and caregiver report including standardized parent report measures. Results: We expand our clinical characterization of HNRNPH2-related disorders to include 33 individuals, aged 2-38 years, both females and males, with 11 different de novo missense variants, most within the nuclear localization signal. The major features of the phenotype include developmental delay/intellectual disability, severe language impairment, motor problems, growth, and musculoskeletal disturbances. Minor features include dysmorphic features, epilepsy, neuropsychiatric diagnoses such as autism spectrum disorder, and cortical visual impairment. Although rare, we report early stroke and premature death with this condition. Conclusions: The spectrum of X-linked HNRNPH2-related disorders continues to expand as the allelic spectrum and identification of affected males increases.Grant support for L. Boyle provided by TL1TR001875.info:eu-repo/semantics/publishedVersio

    Modeling Neuropsychiatric and Neurodegenerative Diseases With Induced Pluripotent Stem Cells

    No full text
    Human-induced pluripotent stem cells (hiPSCs) have revolutionized our ability to model neuropsychiatric and neurodegenerative diseases, and recent progress in the field is paving the way for improved therapeutics. In this review, we discuss major advances in generating hiPSC-derived neural cells and cutting-edge techniques that are transforming hiPSC technology, such as three-dimensional “mini-brains” and clustered, regularly interspersed short palindromic repeats (CRISPR)-Cas systems. We examine specific examples of how hiPSC-derived neural cells are being used to uncover the pathophysiology of schizophrenia and Parkinson’s disease, and consider the future of this groundbreaking research

    Running increases the number of dendritic spines in medial prefrontal cortex and expression of synaptic markers in several regions supporting cognitive function.

    No full text
    <p><i>A</i>, Running increases dendritic spine density on both apical and basal dendrites in the medial prefrontal cortex. <i>B</i>, Representative images of DiI labeled layer 2/3 pyramidal neuron apical dendrites in the medial prefrontal cortex and in sedentary and running animals. Scale Bar = 5 μm. <i>C</i>, Running increases the average length of spine processes. <i>D</i>, Optical intensity analysis of synaptophysin (SYN) reveals increased expression in all regions studied. <i>Inset</i>: example of synaptophysin staining in medial prefrontal cortex. <i>E</i>, PSD-95 levels are also increased in all regions studied. <i>Inset</i>: example of PSD-95 staining in medial prefrontal cortex. Scale Bar = 10 μm. Error bars represent SEM. *<i>p</i><0.05 compared with sedentary for A, C-E.</p

    Running enhances cognitive performance on tasks known to require the medial prefrontal cortex and orbitofrontal cortex.

    No full text
    <p><i>A</i>, Running enhances performance on the object in place (OIP) task, but not on the novel object preference (NOP) task. <i>B</i>, Running results in fewer trials to criterion on the SD, REV and EDS. <i>C</i>, Running results in fewer errors on the SD, REV and EDS. Error bars represent SEM. *<i>p</i><0.05 compared with sedentary rats for A-C. Complex discrimination (CD); intradimensional shift (IDS).</p

    Ovarian cancers overexpress the antimicrobial protein hCAP-18 and its derivative LL-37 increases ovarian cancer cell proliferation and invasion

    No full text
    The role of the pro-inflammatory peptide, LL-37, and its pro-form, human cationic antimicrobial protein 18 (hCAP-18), in cancer development and progression is poorly understood. In damaged and inflamed tissue, LL-37 functions as a chemoattractant, mitogen and pro-angiogenic factor suggesting that the peptide may potentiate tumor progression. The aim of this study was to characterize the distribution of hCAP-18/LL-37 in normal and cancerous ovarian tissue and to examine the effects of LL-37 on ovarian cancer cells. Expression of hCAP-18/LL-37 was localized to immune and granulosa cells of normal ovarian tissue. By contrast, ovarian tumors displayed significantly higher levels of hCAP-18/LL-37 where expression was observed in tumor and stromal cells. Protein expression was statistically compared to the degree of immune cell infiltration and microvessel density in epithelial-derived ovarian tumors and a significant correlation was observed for both. It was demonstrated that ovarian tumor tissue lysates and ovarian cancer cell lines express hCAP-18/LL-37. Treatment of ovarian cancer cell lines with recombinant LL-37 stimulated proliferation, chemotaxis, invasion and matrix metalloproteinase expression. These data demonstrate for the first time that hCAP-18/LL-37 is significantly overexpressed in ovarian tumors and suggest LL-37 may contribute to ovarian tumorigenesis through direct stimulation of tumor cells, initiation of angiogenesis and recruitment of immune cells. These data provide further evidence of the existing relationship between pro-inflammatory molecules and ovarian cancer progression
    corecore